{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T11:58:59Z","timestamp":1790078339172,"version":"4.0.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100012895","name":"Zoetis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012895","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Parasites Vectors"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>A novel chewable oral tablet containing sarolaner, moxidectin and pyrantel (Simparica Trio\u2122) has recently been developed to provide persistent protection against flea and tick infections for a month, treatment of hookworm and roundworm infections and prevention of heartworm and lungworm disease in dogs. Two field studies were conducted to evaluate the safety and efficacy of Simparica Trio\u2122 against natural flea and tick infestations on dogs in Europe.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>Dogs with natural flea or tick infestations were allocated randomly to treatment on Day 0 with either Simparica Trio\u2122 tablets (flea study: <jats:italic>n<\/jats:italic>\u2009=\u2009297; tick study: <jats:italic>n<\/jats:italic>\u2009=\u2009189) to provide 1.2\u20132.4 mg\/kg sarolaner, 24\u201348 \u00b5g\/kg moxidectin and 5\u201310 mg\/kg pyrantel (as pamoate salt) or with NexGard\u00ae Spectra (afoxolaner\u2009+\u2009milbemycin oxime) according to the label instructions (flea study: <jats:italic>n<\/jats:italic>\u2009=\u2009164; tick study: <jats:italic>n<\/jats:italic>\u2009=\u200991). Efficacy was calculated based on the mean percent reduction in live parasite counts compared to the respective pre-treatment counts on Days 14 and 30 in the flea study and on Days 7, 14, 21 and 30 in the tick study. To count the fleas, the dog\u2019s entire coat was systematically combed using an extra fine-tooth flea comb until all fleas were removed. For the tick counts, the dog\u2019s entire coat was searched manually. Resolution of the clinical signs of flea allergy dermatitis (FAD) was assessed in flea allergic dogs in the flea study. Palatability was assessed in both studies.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>Simparica Trio\u2122 was well tolerated in both studies. Efficacy against fleas was\u2009\u2265\u200997.9% in the Simparica Trio\u2122 group and\u2009\u2265\u200996.1% in the NexGard\u00ae Spectra group. Efficacy against ticks was\u2009\u2265\u200994.8% in the Simparica Trio\u2122 group and\u2009\u2265\u200994.4% in the NexGard\u00ae Spectra group. Clinical signs of flea allergy dermatitis improved following treatment with Simparica Trio\u2122. Simparica Trio\u2122 tablets were voluntarily and fully consumed on\u2009\u2265\u200978% of the 485 occasions they were offered.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusions<\/jats:title>\n<jats:p>A single oral dose of Simparica Trio\u2122 was safe and highly efficacious against naturally occurring flea and tick infestations for 1 month on dogs. Clinical signs of FAD improved following treatment. Simparica Trio\u2122 was voluntarily and readily consumed by most dogs.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s13071-020-3946-1","type":"journal-article","created":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:03:04Z","timestamp":1583020984000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Efficacy of a novel oral chewable tablet containing sarolaner, moxidectin and pyrantel (Simparica Trio\u2122) against natural flea and tick infestations on dogs presented as veterinary patients in Europe"],"prefix":"10.1186","volume":"13","author":[{"given":"Csilla","family":"Becskei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daphne","family":"Fias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean P.","family":"Mahabir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Farkas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,3,1]]},"reference":[{"key":"3946_CR1","unstructured":"European Scientific Counsel Companion Animal Parasites. ESCCAP guideline 3: control of ectoparasites in dogs and cats. 6th ed. 2018. https:\/\/www.esccap.org\/uploads\/docs\/mjy50wev_0720_ESCCAP_Guideline_GL3_v9_1p.pdf. Accessed 30 Jan 2020."},{"key":"3946_CR2","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/0304-4017(89)90171-4","volume":"34","author":"MW Dryden","year":"1989","unstructured":"Dryden MW. Host association, on host longevity and egg production of Ctenocephalides felis. Vet Parasitol. 1989;34:117\u201322.","journal-title":"Vet Parasitol."},{"key":"3946_CR3","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1111\/j.1365-3164.2009.00838.x","volume":"20","author":"MW Dryden","year":"2009","unstructured":"Dryden MW. Flea and tick control in the 21st century: challenges and opportunities. Vet Dermatol. 2009;20:435\u201340.","journal-title":"Vet Dermatol."},{"key":"3946_CR4","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/j.ijid.2009.11.011","volume":"14","author":"I Bitam","year":"2010","unstructured":"Bitam I, Dittmar K, Parola P, Whiting MF, Raoult D. Fleas and flea-borne diseases. Int J Infect Dis. 2010;14:667\u201376.","journal-title":"Int J Infect Dis."},{"key":"3946_CR5","doi-asserted-by":"publisher","first-page":"118","DOI":"10.3390\/insects8040118","volume":"8","author":"MK Rust","year":"2017","unstructured":"Rust MK. The biology and ecology of cat fleas and advancements in their pest management: a review. Insects. 2017;8:118.","journal-title":"Insects."},{"key":"3946_CR6","first-page":"2","volume":"26","author":"MW Dryden","year":"2004","unstructured":"Dryden MW, Payne PA. Biology and control of ticks infesting dogs and cats in North America. Vet Ther. 2004;26:2\u201316.","journal-title":"Vet Ther."},{"key":"3946_CR7","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/S1471-4922(00)01856-0","volume":"17","author":"SE Shaw","year":"2001","unstructured":"Shaw SE, Day MJ, Birtles RJ, Breitschwerdt EB. Tick-borne infectious diseases of dogs. Trends Parasitol. 2001;17:74\u201380.","journal-title":"Trends Parasitol."},{"key":"3946_CR8","unstructured":"European Scientific Counsel Companion Animal Parasites. ESCCAP guideline 5: Control of vector-borne diseases in dogs and cats. 3rd ed. 2019. https:\/\/www.esccap.org\/uploads\/docs\/znkh6j1d_0775_ESCCAP_Guideline_GL5_v8_1p.pdf Accessed 30 Jan 2020."},{"key":"3946_CR9","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.vetpar.2013.02.003","volume":"194","author":"AA Marchiondo","year":"2013","unstructured":"Marchiondo AA, Holdsworth PA, Fourie LJ, Rugg D, Hellmann K, Snyder DE, et al. World Association for the Advancement of Veterinary Parasitology (W.A.A.V.P.) second edition: guidelines for evaluating the efficacy of parasiticides for the treatment, prevention and control of flea and tick infestations on dogs and cats. Vet Parasitol. 2013;194:84\u201397.","journal-title":"Vet Parasitol."},{"key":"3946_CR10","unstructured":"European Medicines Agency. Guideline on good clinical practice. VICH Topic GL9. http:\/\/www.ema.europa.eu\/docs\/en%20GB\/document%20library\/Scientific%20guideline\/2009\/10\/WC500004343.pdf. Accessed 12 Apr 2019."},{"key":"3946_CR11","unstructured":"Szab\u00f3 I. Bolh\u00e1k Siphonaptera. In: Fauna Hungariae 123., volume XV: 18. Budapest: Akad\u00e9miai Kiad\u00f3; 1975. p. 1\u201396. (in Hungarian)."},{"key":"3946_CR12","volume-title":"Ticks of domestic animals in the Mediterranean region: a guide to identification of species","author":"A Estrada-Pe\u00f1a","year":"2004","unstructured":"Estrada-Pe\u00f1a A, Bouattour A, Camicas JL, Walker AR. Ticks of domestic animals in the Mediterranean region: a guide to identification of species. Zaragoza: University of Zaragoza; 2004."},{"key":"3946_CR13","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/1756-3305-7-83","volume":"7","author":"N Rohdich","year":"2014","unstructured":"Rohdich N, Roepke RK, Zschiesche E. A randomized, blinded, controlled and multi-centered field study comparing the efficacy and safety of Bravecto\u2122 (fluralaner) against Frontline\u2122 (fipronil) in flea-and tick-infested dogs. Parasit Vectors. 2014;7:83.","journal-title":"Parasit Vectors."},{"key":"3946_CR14","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.vetpar.2016.02.007","volume":"222","author":"C Becskei","year":"2016","unstructured":"Becskei C, De Bock F, Illambas J, Mahabir SP, Farkas R, Six RH. Efficacy and safety of a novel oral isoxazoline, sarolaner (Simparica\u2122) in the treatment of naturally occurring flea and tick infestations in dogs presented as veterinary patients in Europe. Vet Parasitol. 2016;222:49\u201355.","journal-title":"Vet Parasitol."},{"key":"3946_CR15","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1186\/s13071-017-2479-8","volume":"10","author":"D Cavalleri","year":"2017","unstructured":"Cavalleri D, Murphy M, Seewald W, Drake J, Nanchen S. A randomised, blinded, controlled field study to assess the efficacy and safety of lotilaner tablets (Credelio\u2122) in controlling fleas in client-owned dogs in European countries. Parasit Vectors. 2017;10:526.","journal-title":"Parasit Vectors."},{"key":"3946_CR16","doi-asserted-by":"publisher","DOI":"10.1136\/vr.100211","author":"S Wolken","year":"2011","unstructured":"Wolken S, Franc M, Bouhsira E, Wiseman S, Hayes B, Schnitzler B, et al. Evaluation of spinosad for the oral treatment and control of flea infestations on dogs in Europe. Vet Rec. 2011. https:\/\/doi.org\/10.1136\/vr.100211.","journal-title":"Vet Rec."},{"key":"3946_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/s13071-020-3944-3","author":"K Kryda","year":"2020","unstructured":"Kryda K, Becskei C, Mahabir SP, Carter L, Everett WR, Young DR, et al. Laboratory studies evaluating the efficacy of a novel orally administered combination product containing sarolaner, moxidectin and pyrantel (Simparica Trio\u2122) for the treatment and control of flea infestations on dogs. Parasit Vectors. 2020. https:\/\/doi.org\/10.1186\/s13071-020-3944-3 (In press, this Collection).","journal-title":"Parasit Vectors."},{"key":"3946_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0304-4017(94)90031-0","volume":"52","author":"MW Dryden","year":"1994","unstructured":"Dryden MW. Rust MK The cat flea: biology, ecology and control. Vet Parasitol. 1994;52:1\u201319.","journal-title":"Vet Parasitol."},{"key":"3946_CR19","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1146\/annurev.ento.42.1.451","volume":"42","author":"MK Rust","year":"1997","unstructured":"Rust MK, Dryden MW. The biology, ecology, and management of the cat flea. Annu Rev Entomol. 1997;42:451\u201373.","journal-title":"Annu Rev Entomol."},{"key":"3946_CR20","first-page":"7","volume":"3","author":"CA Sousa","year":"1997","unstructured":"Sousa CA. Feas, flea allergy, and flea control, a review. Dermatol Online J. 1997;3:7.","journal-title":"Dermatol Online J."},{"key":"3946_CR21","first-page":"10","volume":"19","author":"MW Dryden","year":"1989","unstructured":"Dryden MW, Blakemore JC. A review of flea allergy dermatitis in the dog and cat. Companion Anim Pract. 1989;19:10\u20137.","journal-title":"Companion Anim Pract."},{"key":"3946_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/s13071-020-3952-3","author":"K Kryda","year":"2020","unstructured":"Kryda K, Mahabir SP, Inskeep T, Rugg J. Safety and efficacy of a novel oral chewable combination tablet containing sarolaner, moxidectin and pyrantel (Simparica Trio\u2122) against fleas on dogs presented as veterinary patients in the USA. Parasit Vectors. 2020. https:\/\/doi.org\/10.1186\/s13071-020-3952-3 (In press, this Collection).","journal-title":"Parasit Vectors."},{"key":"3946_CR23","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1186\/s13071-017-2478-9","volume":"10","author":"D Cavalleri","year":"2017","unstructured":"Cavalleri D, Murphy M, Seewald W, Drake J, Nanchen S. A randomized, controlled study to assess the efficacy and safety of lotilaner (Credelio\u2122) in controlling ticks in client-owned dogs in Europe. Parasit Vectors. 2017;10:531.(In press, this Collection)","journal-title":"Parasit Vectors."},{"key":"3946_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/s13071-020-3949-y","author":"C Becskei","year":"2020","unstructured":"Becskei C, Liebenberg J, Thys M, Mahabir SP. Efficacy of a novel chewable tablet containing sarolaner, moxidectin and pyrantel (Simparica Trio\u2122) against four common tick species infesting dogs in Europe. Parasit Vectors. 2020. https:\/\/doi.org\/10.1186\/s13071-020-3949-y.","journal-title":"Parasit Vectors."},{"key":"3946_CR25","unstructured":"Companion Animal Parasite Council. CAPC guideline on ticks for dogs. 2017. https:\/\/capcvet.org\/guidelines\/ticks\/. Accessed 12 June 2019."},{"key":"3946_CR26","first-page":"742","volume":"25","author":"L Kidd","year":"2003","unstructured":"Kidd L, Breitschwerdt EB. Transmission times and prevention of tick-borne diseases in dogs. Compend Contin Educ Pract. Vet. 2003;25:742\u201351.","journal-title":"Compend Contin Educ Pract. Vet."},{"key":"3946_CR27","unstructured":"Little SE. Changing paradigms in understanding transmission of canine tick-borne diseases: the role of interrupted feeding and intrastadial transmission. In: 2nd Canine Vector-Borne Disease (CVBD) Symposium, Mezara del Vallo, Sicily, Italy; 2007. p. 30\u20134."},{"key":"3946_CR28","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1097\/MAJ.0b013e3181e93817","volume":"340","author":"LJ Salinas","year":"2010","unstructured":"Salinas LJ, Greenfield RA, Little SE, Voskuhl GW. Tickborne infections in the southern United States. Am J Med Sci. 2010;340:194\u2013201.","journal-title":"Am J Med Sci."},{"key":"3946_CR29","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1186\/s13071-019-3702-6","volume":"12","author":"K Kryda","year":"2019","unstructured":"Kryda K, Six RH, Walsh KF, Holzmer SJ, Chapin S, Mahabir SP, et al. Laboratory and field studies to investigate the efficacy of a novel, orally administered combination product containing sarolaner, moxidectin and pyrantel for the prevention of heartworm disease (Dirofilaria immitis) in dogs. Parasit Vectors. 2019;12:445.","journal-title":"Parasit Vectors."},{"key":"3946_CR30","doi-asserted-by":"publisher","DOI":"10.1186\/s13071-020-3948-z","author":"C Becskei","year":"2020","unstructured":"Becskei C, Thys M, Doherty P, Mahabir SP. Efficacy of orally administered combination of moxidectin, sarolaner and pyrantel (Simparica Trio\u2122) for the prevention of experimental Angiostrongylus vasorum infection in dogs. Parasit Vectors. 2020. https:\/\/doi.org\/10.1186\/s13071-020-3948-z (In press, this Collection).","journal-title":"Parasit Vectors."},{"key":"3946_CR31","doi-asserted-by":"publisher","DOI":"10.1186\/s13071-020-3950-5","author":"C Becskei","year":"2020","unstructured":"Becskei C, Kryda K, Thys M, Holzmer S, Bowersock L, Fernandes T, et al. Efficacy of a new oral chewable tablet containing sarolaner, moxidectin and pyrantel (Simparica Trio\u2122) against induced ascarid infections in dogs. Parasit Vectors. 2020. https:\/\/doi.org\/10.1186\/s13071-020-3950-5 (In press, this Collection).","journal-title":"Parasit Vectors."},{"key":"3946_CR32","doi-asserted-by":"publisher","DOI":"10.1186\/s13071-020-3951-4","author":"C Becskei","year":"2020","unstructured":"Becskei C, Thys M, Kryda K, Meyer L, Martorell S, Geurden T, et al. Efficacy of Simparica Trio\u2122, a novel chewable tablet containing sarolaner, moxidectin and pyrantel, against induced hookworm infections in dogs. Parasit Vectors. 2020. https:\/\/doi.org\/10.1186\/s13071-020-3951-4 (In press, this Collection).","journal-title":"Parasit Vectors."}],"container-title":["Parasites &amp; Vectors"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13071-020-3946-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13071-020-3946-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13071-020-3946-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:05:36Z","timestamp":1614557136000},"score":1,"resource":{"primary":{"URL":"https:\/\/parasitesandvectors.biomedcentral.com\/articles\/10.1186\/s13071-020-3946-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,1]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["3946"],"URL":"https:\/\/doi.org\/10.1186\/s13071-020-3946-1","relation":{},"ISSN":["1756-3305"],"issn-type":[{"value":"1756-3305","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,1]]},"assertion":[{"value":"23 July 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 March 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The protocols were reviewed and approved by the Zoetis ethics review assessment team prior to implementation. Informed owner consent was obtained prior to the enrollment of all dogs.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"This study was funded by Zoetis, Parsippany, NJ, USA. CB, DF and SPM were employees of Zoetis.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"72"}}